Risk factors and prognosis for clot formation on cardiac device leads

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 10, 2013, Pages 1294-1300

  Rahbar, Ata Soleimani ^a   Azadani, Peyman N ^b   Thatipelli, Sindhura ^a   Fleischmann, Kirsten E ^a   Nguyen, Nhunhu ^a   Lee, Byron K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

artificial pacemaker; heart atria; implantable cardioverter defibrillators; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; DEVICES; EMBOLISM; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE; THROMBUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ARTIFICIAL PACEMAKER; HEART ATRIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; THROMBOSIS;

CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO; THROMBOSIS;

EID: 84886432337     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12210     Document Type: Article

References (10)

1. Cengiz M, Okutucu S, Ascioglu S, Sahin A, Aksoy H, Sinan Deveci O, Baris Kaya E, et al. Permanent pacemaker and implantable cardioverter defibrillator infections: Seven years of diagnostic and therapeutic experience of a single center. Clin Cardiol 2010, 33: 406-411.
2. van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L,. Implantation-related complications of implantable cardioverter- defibrillators and cardiac resynchronization therapy devices: A systematic review of randomized clinical trials. J Am Coll Cardiol 2011, 58: 995-1000.
3. Ren JF, Marchlinski FE,. Intracardiac echocardiographic detection of mobile echodensities adherent to the intracardiac leads. JACC Cardiovasc Imaging 2010, 3: 895-896; Author reply 896.
4. Novak M, Dvorak P, Kamaryt P, Slana B, Lipoldova J,. Autopsy and clinical context in deceased patients with implanted pacemakers and defibrillators: Intracardiac findings near their leads and electrodes. Europace 2009, 11: 1510-1516.
5. Supple GE, Ren JF, Zado ES, Marchlinski FE,. Mobile thrombus on device leads in patients undergoing ablation: Identification, incidence, location, and association with increased pulmonary artery systolic pressure. Circulation 2011, 124: 772-778.
6. Coleman DB, DeBarr DM, Morales DL, Spotnitz HM,. Pacemaker lead thrombosis treated with atrial thrombectomy and biventricular pacemaker and defibrillator insertion. Ann Thorac Surg 2004, 78: e83-84.
7. Sugiura S, Fujii E, Senga M, Sugiura E, Nakamura M, Ito M,. Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy. J Interv Card Electrophysiol 2012; 34: 59-63.
8. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS,. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005, 112: 1687-1691.
9. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lua CP, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129.
10. Lafitte S, Pillois X, Reant P, Picard F, Arsac F, Dijos M, Coste P, et al. Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by doppler echocardiography: A retrospective comparison of routine echocardiography and invasive hemodynamics. J Am Soc Echocardiogr 2013; 26: 457-463.